TA-V Nanozymes with Acid Resistance Capabilities Effectively Target and Alleviate Ulcerative Colitis Lesions via Oral Delivery
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c20322 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Zhenzhen Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Tannins, Antioxidants. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Anhui Medical University, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
As one of the most common inflammatory bowel diseases (IBDs), ulcerative colitis (UC) has become a rising global health issue that affects people's quality of life. Conventional therapeutic drugs have low bioavailability and may cause serious side effects due to their lack of acidic resistance and lesion-targeting capabilities. The development of novel nanomedicines to overcome these problems is urgently needed. Nanozymes have attracted attention because of their excellent catalytic efficiency in various harsh environments. In this study, tannic acid-vanadium (TA-V) nanozymes with multienzymatic and excellent antioxidant abilities, which exhibit acidic resistance and a negative surface charge, were successfully developed. All these characteristics make it possible that these nanozymes are not easily decomposed by gastric acid and can effectively accumulate in colitis lesions with a positive charge through oral delivery. In vitro and in vivo experiments further demonstrated the excellent prophylactic and therapeutic value of these compounds in the treatment of UC by scavenging reactive oxygen/nitrogen species (ROS/RNS) and mitigating the oxidative stress environment, thus downregulating the levels of the proinflammatory cytokines IL-1β, IL-6, and TNF-α. Furthermore, TA-V also showed excellent biosafety and biocompatibility without causing obvious damage to the main organs. This work provides novel preventative and therapeutic TA-V nanozymes that might have potential clinical applications in UC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P. R. China.
- School of Food and Biological Engineering, Hefei University of Technology, Hefei 230009, P. R. China.
- School of Biomedical Engineering, Anhui Medical University, Hefei 230032, P. R. China.
- Anhui Province Key Laboratory of Occupational Health, Anhui No. 2 Provincial People's Hospital, Hefei 230041, P. R. China.
ORCID-Profile: Xianwen Wang
Förderung
- Anhui Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Distinguished Youth of Natural Science Research Projects in Anhui Province Universities
- Anhui Province Excellent Research and Innovation Team Project
- Excellent Youth of Natural Science Research Projects in Anhui Province Universities
Zitieren
APA
Jin, Z., Cao, X., Guo, Q., Zhang, C., Li, Q., Wang, W., Lv, Y., Ma, Y., & Wang, X. (2025). TA-V Nanozymes with Acid Resistance Capabilities Effectively Target and Alleviate Ulcerative Colitis Lesions via Oral Delivery. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c20322
Vancouver
Jin Z, Cao X, Guo Q, Zhang C, Li Q, Wang W, et al. TA-V Nanozymes with Acid Resistance Capabilities Effectively Target and Alleviate Ulcerative Colitis Lesions via Oral Delivery. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c20322
BibTeX
@article{Jin2025,
author = {Jin, Zhenzhen and Cao, Xiangjing and Guo, Qinglong and Zhang, Cong and Li, Qingrong and Wang, Wenqi and Lv, Yong and Ma, Yan and Wang, Xianwen},
title = {TA-V Nanozymes with Acid Resistance Capabilities Effectively Target and Alleviate Ulcerative Colitis Lesions via Oral Delivery},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c20322}
}
EUVIMED